Oncopeptides AB (0RN4.LSE) Q4 2024 Earnings

7NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.74
-0.51
-0.28
-0.05

Details

Expected EPS
N/A
Actual EPS
-0.3035531674
Surprise EPS
-0.3
Surprise Percent
+∞%

Description

Oncopeptides AB (0RN4.LSE) has reported earnings of -0.3035531674 per share for Q4 2024.

0 Comments

Share your thoughts